IFX-1-P2.6: A randomized, double-blind, placebo-controlled, multicenter, parallel-group Phase II study toinvestigate the safety and efficacy of two different dose regimens of IFX-1 as add-on to standard of care insubjects with granulomatosis with polya

Project: Research project

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry